BioNTech SE (BNTX) Net Cash Flow Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -2,045.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,045.25% |
| Sep 30, 2025 | 91.84% |
| Jun 30, 2025 | -101.03% |
| Mar 31, 2025 | 70.74% |
| Dec 31, 2024 | 107.28% |
| Sep 30, 2024 | 79.33% |
| Jun 30, 2024 | -30.22% |
| Mar 31, 2024 | -56.18% |
| Dec 31, 2023 | -311.61% |
| Sep 30, 2023 | -119.16% |
| Jun 30, 2023 | -37.18% |
| Mar 31, 2023 | -2,129.52% |
| Dec 31, 2022 | 928.72% |
| Sep 30, 2022 | 129.55% |
| Jun 30, 2022 | 882.37% |
| Mar 31, 2022 | -78.00% |
| Dec 31, 2021 | 65.41% |
| Sep 30, 2021 | 84.02% |
| Jun 30, 2021 | 80.42% |
| Mar 31, 2021 | 418.25% |
| Dec 31, 2020 | 14.52% |
| Sep 30, 2020 | 177.16% |
| Jun 30, 2020 | 136.68% |
| Mar 31, 2020 | 6.42% |
| Dec 31, 2019 | 12.02% |